Help:WikiPathways Portals
From WikiPathways
(Difference between revisions)
(removed the word portal) |
(updated order and added new ones) |
||
| Line 11: | Line 11: | ||
* [[Portal:Disease/COVIDPathways|COVID-19]] | * [[Portal:Disease/COVIDPathways|COVID-19]] | ||
| - | |||
| - | |||
* [[Portal:Blau|Blau Pathways]] | * [[Portal:Blau|Blau Pathways]] | ||
* [[Portal:SkeletalDysplasia|Skeletal Dysplasia]] | * [[Portal:SkeletalDysplasia|Skeletal Dysplasia]] | ||
| + | * [[Portal:Lipids|Lipids Pathways]] | ||
| + | * [[Portal:AOP|Adverse Outcome Pathway]] | ||
* [[Portal:CPTAC|Clinical Proteomic Tumor Analysis Consortium Pathway]] | * [[Portal:CPTAC|Clinical Proteomic Tumor Analysis Consortium Pathway]] | ||
* [[Portal:RenalGenomics|Renal Genomics]] | * [[Portal:RenalGenomics|Renal Genomics]] | ||
Revision as of 17:26, 27 August 2020
Portals within WikiPathways serve as organizing points for communities with focused pathway interests. For example, a portal could organize pathways for a particular species or research area. The main advantages of portals include:
- Simplifying drawing and databasing of your pathways
- Help to keep track of ‘works-in-progress’ with collaborators
- Help attribute credit for pathway authors and curators
- Attract new collaborators
- Help to define a community
Creating a portal is easy using existing templates available from WikiPathways. If you are interested, please consult the portal maintenance guide and contact us for assistance.
WikiPathways has a growing list of portals:
- COVID-19
- Blau Pathways
- Skeletal Dysplasia
- Lipids Pathways
- Adverse Outcome Pathway
- Clinical Proteomic Tumor Analysis Consortium Pathway
- Renal Genomics
- Disease and Rare Disease
- ExRNA Pathway
- Micronutrients
- Nanomaterials Pathways
- NetPath
- Plant Pathways
- Reactome
- WormBase
- California Institute for Regenerative Medicine, CIRM
